Envela (ELA) Q4 EPS of $0.23 Crushes Estimate by 156%, Revenue Surges 66.6% YoY to $80.5M
Envela's Q4 EPS of $0.23 crushed the $0.09 estimate by $0.14 per share, while revenue of $80.5M topped consensus by…
ADVERTISEMENT
Company News
Heartflow (HTFL) Stock Surges 13% as Q4 Revenue of $49.1M Beats Estimates Despite $0.12 Loss
Heartflow posts wider-than-expected Q4 loss of $0.29/share but revenue tops estimates by 5.6%, driving 13% stock surge on growth optimism.
DLocal’s Strong 2025 Finish
DLocal's Q4 EPS of $0.36 crushed the $0.18 estimate by 96%, while revenue of $337.9M beat consensus and surged 65%…
Micron Technology’s Fiscal Q2 2026 Financial Review
Micron crushes Q2 estimates with $12.20 EPS vs $8.73 consensus, revenue up 196% YoY to $23.86B as AI memory demand…
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates
Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.
General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B
General Mills Q3 EPS of $0.64 missed estimates by 12.1% as strategic pricing investments weighed on results; management reaffirms guidance,…
Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M
Star Equity posts Q4 loss of $0.10 per share, missing estimates by 152.6%, despite 69% revenue growth to $56.8M.
Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25
Ovid Therapeutics swings to $0.06 EPS profit versus -$0.10 estimate, reversing year-ago loss with $9.7M net income on $700K revenue.
ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff
CEO Adam Grossman sold 15,000 shares at $15.16, part of a broader pattern of net insider selling totaling 125,192 shares…
AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares
CEO John Gregory Turner forfeited 16,130 shares at $13.60 for tax withholding, part of a six-month pattern showing 582,124 net…